ProCE Banner Activity

New Findings in Lung Cancer From WCLC 2021: A Focus on Immunotherapy

Clinical Thought
Review some of the notable studies presented at WCLC 2021 related to immunotherapy and more from Shirish Gadgeel, MD.

Released: October 05, 2021

Expiration: October 04, 2022

No longer available for credit.

Share

Faculty

Shirish Gadgeel

Shirish Gadgeel, MD

Professor
Division of Hematology/Oncology
Department of Internal Medicine
University of Michigan
Ann Arbor, Michigan

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genentech, a member of the Roche Group

Helsinn Healthcare SA

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Shirish Gadgeel, MD

Professor
Division of Hematology/Oncology
Department of Internal Medicine
University of Michigan
Ann Arbor, Michigan

Shirish M. Gadgeel, MD, has disclosed that he has received consulting fees from AstraZeneca, Blueprint, Boehringer Ingelheim, Bristol-Myers Squibb, Daichii-Sanyko, Janssen, Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche/Genentech, and Takeda; fees for non-CME/CE services from Merck Sharp & Dohme and Xcovery; and other financial or material support from AstraZeneca and Roche/Genentech.